Holen Sie sich die Stockscreener-App
1.98
5.71%
-0.12
Handel nachbörslich:
1.97
-0.01
-0.51%
Schlusskurs vom Vortag:
$2.10
Offen:
$2.12
24-Stunden-Volumen:
102.09K
Relative Volume:
0.44
Marktkapitalisierung:
$83.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.94%
1M Leistung:
-56.77%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.92
$2.12
1-Wochen-Bereich:
$1.80
$2.29
52-Wochen-Spanne:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Firmenname
Tuhura Biosciences Inc
Sektor
Branche
Telefon
813-875-6600
Adresse
10500 UNIVERSITY CENTER DR., TAMPA
Vergleichen Sie HURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
1.98 | 83.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-11-05 | Eingeleitet | Maxim Group | Buy |
Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
TuHURA Biosciences Expands Board with New Appointment - TipRanks
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors - Joplin Globe
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference - Weatherford Democrat
What is HC Wainwright’s Estimate for HURA Q2 Earnings? - Defense World
KINETA, INC./DE SEC 10-K Report - TradingView
TuHURA Biosciences (NASDAQ:HURA) Now Covered by Analysts at HC Wainwright - Defense World
HC Wainwright Initiates TuHURA Biosciences at Buy With $13 Price Target -March 03, 2025 at 07:29 am EST - Marketscreener.com
TuHURA Biosciences (HURA) to Release Earnings on Wednesday - Defense World
TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Milton Daily Standard
Apollon Wealth Management LLC Invests $253,000 in TuHURA Biosciences (NASDAQ:HURA) - MarketBeat
TuHURA Biosciences: A Hold On Only The Faintest Glimmers Of Efficacy (NASDAQ:HURA) - Seeking Alpha
TuHURA Biosciences secures $3M through warrant exercises By Investing.com - Investing.com Australia
TuHURA Biosciences secures $3M through warrant exercises - Investing.com India
Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger - Fierce Biotech
Equities Analysts Offer Predictions for HURA Q2 Earnings - MarketBeat
TuHURA Biosciences (HURA) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Research Analysts Issue Forecasts for HURA Q2 Earnings - Defense World
TuHURA Biosciences’ Acquisition of Kineta - Global Legal Chronicle
HURA: Initiating an Immune Response - Yahoo Finance
TuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6%Here's Why - MarketBeat
TuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% – Here’s What Happened - Defense World
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - ACCESS Newswire
When Will TuHURA Biosciences, Inc. (NASDAQ:HURA) Turn A Profit? - Simply Wall St
When Can We Expect A Profit From TuHURA Biosciences, Inc. (NASDAQ:HURA)? - Yahoo Finance
Analyzing Enveric Biosciences (NASDAQ:ENVB) and TuHURA Biosciences (NASDAQ:HURA) - Defense World
Rep. Laurel M. Lee Purchases Shares of TuHURA Biosciences (NASDAQ:HURA) - Defense World
Rep. Laurel M. Lee Buys TuHURA Biosciences (NASDAQ:HURA) Shares - MarketBeat
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc.HURA - The Eastern Progress Online
TuHURA Biosciences appoints new accounting firm By Investing.com - Investing.com Australia
TuHURA Biosciences appoints new accounting firm - Investing.com India
TuHURA Biosciences (NASDAQ:HURA) Upgraded to "Strong-Buy" at RODMAN&RENSHAW - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders - Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders - Finansavisen
H.C. Wainwright sets $11 target on HURA with buy rating - Investing.com
Cancer Immunotherapy: TuHURA Biosciences to Acquire Kineta - orrick.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders - Finansavisen
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders - GlobeNewswire
Finanzdaten der Tuhura Biosciences Inc-Aktie (HURA)
Es liegen keine Finanzdaten für Tuhura Biosciences Inc (HURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.39%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):